MB "Pharmafina" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
0 |
- |
0 |
0 |
- |
- |
- |
- |
- |
0 |
0 |
0 |
0 |
2023 |
---|
1,571 |
- |
1,512 |
1,512 |
- |
0.96 |
0.04 |
100.00 |
96.24 |
1,514 |
59 |
0 |
1,573 |
2024 |
---|
197,642 |
- |
151,939 |
144,896 |
- |
0.74 |
0.05 |
100.00 |
73.31 |
146,409 |
7,043 |
0 |
153,452 |
Register and
explore Okredo data2024 |
---|
197,642 |
- |
151,939 |
144,896 |
- |
0.74 |
0.05 |
100.00 |
73.31 |
146,409 |
7,043 |
0 |
153,452 |
Register and
explore Okredo data2024
Turnover (€)
197,642 €12,481 % *
Sales per employee (€)
-Profit before tax (€)
151,939 €9,949 % *
Net Profit (€)
144,896 €9,483 % *
Profit per employee (€)
-Working capital requirement
0.74 -22.92 % *
Debt-to-equity ratio
0.05 25.00 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
73.31 %-23.83 % *
Equity (€)
146,409 €9,570 % *
Amounts Payable And Liabilities (€)
7,043 €11,837 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
153,452 €9,655 % *